Aptamers for Targeted Therapy

Ge Yang; Yuanyu Huang

doi:10.1007/978-981-33-4838-7_6

Aptamers for Targeted Therapy

Ge Yang, Yuanyu Huang^*

^*Corresponding author for this work

System Engineering Research Institute of Engineering Equipment

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

This chapter introduces the aptamers for targeted therapy. Aptamers show promising efficacy and safety in four types of clinical studies of ophthalmopathy, blood coagulation, inflammation, and cancer, and there are increasing numbers of evidences to prove the clinical application potential of aptamers. To date, more than a dozen aptamers have entered clinical trials as therapeutic agents for targeted therapy. This chapter introduces their pharmacological development and optimization processes and reviews potential treatment of diseases.

Original language	English
Title of host publication	Aptamers for Medical Applications
Subtitle of host publication	From Diagnosis to Therapeutics
Publisher	Springer Singapore
Pages	129-178
Number of pages	50
ISBN (Electronic)	9789813348387
ISBN (Print)	9789813348370
DOIs	https://doi.org/10.1007/978-981-33-4838-7_6
Publication status	Published - 1 Jan 2021
Externally published	Yes

Keywords

Aptamers
Cancer
Coagulation
Inflammation
Oculopathy
Target therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-981-33-4838-7_6

Cite this

@inbook{2ea265fc4fbd4d85b5af82cb712fe3eb,

title = "Aptamers for Targeted Therapy",

abstract = "This chapter introduces the aptamers for targeted therapy. Aptamers show promising efficacy and safety in four types of clinical studies of ophthalmopathy, blood coagulation, inflammation, and cancer, and there are increasing numbers of evidences to prove the clinical application potential of aptamers. To date, more than a dozen aptamers have entered clinical trials as therapeutic agents for targeted therapy. This chapter introduces their pharmacological development and optimization processes and reviews potential treatment of diseases.",

keywords = "Aptamers, Cancer, Coagulation, Inflammation, Oculopathy, Target therapy",

author = "Ge Yang and Yuanyu Huang",

note = "Publisher Copyright: {\textcopyright} Springer Nature Singapore Pte Ltd. 2021.",

year = "2021",

month = jan,

day = "1",

doi = "10.1007/978-981-33-4838-7_6",

language = "English",

isbn = "9789813348370",

pages = "129--178",

booktitle = "Aptamers for Medical Applications",

publisher = "Springer Singapore",

address = "Singapore",

}

TY - CHAP

T1 - Aptamers for Targeted Therapy

AU - Yang, Ge

AU - Huang, Yuanyu

N1 - Publisher Copyright: © Springer Nature Singapore Pte Ltd. 2021.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - This chapter introduces the aptamers for targeted therapy. Aptamers show promising efficacy and safety in four types of clinical studies of ophthalmopathy, blood coagulation, inflammation, and cancer, and there are increasing numbers of evidences to prove the clinical application potential of aptamers. To date, more than a dozen aptamers have entered clinical trials as therapeutic agents for targeted therapy. This chapter introduces their pharmacological development and optimization processes and reviews potential treatment of diseases.

AB - This chapter introduces the aptamers for targeted therapy. Aptamers show promising efficacy and safety in four types of clinical studies of ophthalmopathy, blood coagulation, inflammation, and cancer, and there are increasing numbers of evidences to prove the clinical application potential of aptamers. To date, more than a dozen aptamers have entered clinical trials as therapeutic agents for targeted therapy. This chapter introduces their pharmacological development and optimization processes and reviews potential treatment of diseases.

KW - Aptamers

KW - Cancer

KW - Coagulation

KW - Inflammation

KW - Oculopathy

KW - Target therapy

UR - http://www.scopus.com/inward/record.url?scp=85150585355&partnerID=8YFLogxK

U2 - 10.1007/978-981-33-4838-7_6

DO - 10.1007/978-981-33-4838-7_6

M3 - Chapter

AN - SCOPUS:85150585355

SN - 9789813348370

SP - 129

EP - 178

BT - Aptamers for Medical Applications

PB - Springer Singapore

ER -

Aptamers for Targeted Therapy

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this